Hengao Pukang (恒奥普康)恒奥普康
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江尖峰药业有限公司Chinese legal name: 浙江尖峰药业有限公司
主要成分Active Ingredients
- 喷昔洛韦Penxi Luowei
药物知识说明
喷昔洛韦是一种在国家药监局注册认定的药品。该药品含有喷昔洛韦-3e6a1b03等成分。
该药品关联的活性成分包括：喷昔洛韦Penxi Luowei。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：浙江尖峰药业有限公司Chinese legal name: 浙江尖峰药业有限公司。
您可以探索含有相同成分的其他药品：喷昔洛韦-3e6a1b03成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 恒奥普康) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 喷昔洛韦Penxi Luowei.
Manufacturers recorded for this product: 浙江尖峰药业有限公司Chinese legal name: 浙江尖峰药业有限公司.
Explore other medicines containing the same ingredient: 喷昔洛韦 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 恒奥普康Recorded Chinese name: 恒奥普康
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 管制抗生素瓶装，1瓶/盒。每瓶0.25g。Recorded Chinese description: 管制抗生素瓶装，1瓶/盒。每瓶0.25g。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 浙江尖峰药业有限公司Chinese legal name: 浙江尖峰药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20070186
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20070186
Manufacturer
Chinese legal name: 浙江尖峰药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20070186
生产企业
浙江尖峰药业有限公司(国产)
适应症
本品适用于严重带状疱疹患者，如出血性带状疱疹，坏疽性带状疱疹，播散性带状疱，三叉神经支带状疱疹，带状疱疹脑膜炎，严重疼痛的早期带状疱疹等和免役机能障碍并发的带状疱疹。
用法用量
一次每公斤体重5mg，一日2次，隔12小时滴注一次，每次滴注时间应持续1小时以上。
不良反应
尚不明确。
禁忌
对更昔洛韦过敏者也可能对本品过敏。
注意事项
1. 对更昔洛韦过敏者也可能对本品过敏。2. 本品为静脉滴注用药，忌用作其它途径给药。3. 静脉滴注时应缓慢(1小时以上)，防止局部浓度过高，引起疼痛及炎症。4. 溶液配制后应立即使用，不能冷藏，因冷藏时会析出结晶，用剩溶液应废弃，稀释药液时出现白色浑浊或结晶则不能使用。5. 本品呈碱性，与其它药物混合时易引起溶液PH值改变，应尽量避免配伍使用。6. 有肾脏疾病，脱水或同时使用其它对肾脏有毒性药物的病人，应调整剂量，缓慢静脉滴注(1小时以上)。
贮藏
密闭，阴凉保存
规格
管制抗生素瓶装，1瓶/盒。每瓶0.25g。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.